[Recalled] Zippie IRIS Wheelchair. model EIZ5A in combination with option code 188M02 - MONO Backrest system with Dynamic Backrest option. Provide mobility to persons limited to a sitting position. — Quickie IRIS and Zippie IRIS tilt-in-sp
This is an official product-safety recall record. Below are the verified details from the issuing authority, in plain language.
Recall details
| Product | Zippie IRIS Wheelchair. model EIZ5A in combination with option code 188M02 - MONO Backrest system with Dynamic Backrest option. Provide mobility to persons limited to a sitting position. |
|---|---|
| Brand / manufacturer | Sunrise Medical (US) LLC |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-2466-2015 |
| Country of notice | United States |
| Risk level | Class II |
| Hazard type | recall |
| Notice date | 27 July 2015 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: Quickie IRIS and Zippie IRIS tilt-in-space wheelchairs with MONO Backrest System with Dynamic Backrest may break over time resulting in a fall or injury to occupant.
This Class II recall concerns device products distributed in United States and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Check whether your unit is affected and follow the authority's guidance before further use.
Read the full official notice →
Related recalls from Sunrise Medical (US) LLC
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.
- Education on Safety and Ingredients: What Every Parent Should Know
- RoHS Compliance Electronics Guide: A Consumer's Handbook
- How to Factory Reset a Google Pixel 8: Step by Step
- Top Rated Eye Care Brands: A Comprehensive Guide to Healthy, Glowing Eyes
- Top Rated Water Brands for Every Lifestyle
- Qu'est-ce que 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one (CAS 119344-86-4) ? Sécurité, réglementation & perspective UE/États-Unis/Canada | ProductGuru